Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
AboaPharm Oy
OY
Active
Y-tunnus 1990896-7
Sammonkatu 75, 33540
Tampere
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2005 · 20 years old
9 employees
Share
Finland
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
AboaPharm Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
7M
6M
4M
2M
0M
2021: 3M
3M
2021
2022: 3M (0% vs 2021)
3M
0%
2022
2023: 3M (0% vs 2022)
3M
0%
2023
2024: 3M (0% vs 2023)
3M
0%
2024
2025: 6M (+100% vs 2024)
6M
+100%
2025
EBITDA
EUR millions
2M
2M
1M
1M
0M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 1M
1M
2023
2024: 1M (0% vs 2023)
1M
0%
2024
2025: 2M (+100% vs 2024)
2M
+100%
2025
Income statement
EUR thousands
Item
2025
2024
2023
2022
2021
Revenue
6 495
3 235
3 239
3 326
3 344
Staff expenses
−254
−326
−312
−472
−530
EBITDA
1 675
744
664
484
415
Depreciation & amort.
−141
−145
−145
−130
−163
EBIT
1 534
598
519
353
252
Net financials
56
18
158
−24
−26
Profit before tax
1 589
617
677
329
226
Tax
318
123
128
74
50
Net profit
1 271
494
549
255
176
Balance sheet
EUR thousands
Item
2025
2024
2023
2022
2021
Total assets
5 136
3 509
3 326
3 114
3 194
Equity
3 994
2 962
2 693
2 334
2 271
Long-term debt
231
84
145
217
328
Short-term debt
911
463
488
562
596
Total debt
1 142
547
633
780
923
Financial ratios
5-year trend
EBITDA margin
25,8 %
This company
15,8 %
Market median
This company
Market median
63% above market
2021
2025
Equity ratio
77,8 %
This company
38,2 %
Market median
This company
Market median
104% above market
2021
2025
Return on equity
31,8 %
This company
18,4 %
Market median
This company
Market median
73% above market
2021
2025
Net profit margin
19,6 %
This company
8,1 %
Market median
This company
Market median
142% above market
2021
2025
Asset turnover
1,26×
This company
1,12×
Market median
This company
Market median
12% above market
2021
2025
Debt / equity
0,29×
This company
0,62×
Market median
This company
Market median
53% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
More on AboaPharm Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
